English

CollabRx, Inc.

EDGAR

RNVA Annual report (10-K) · filed 2025-02-14

191 filing records in this dataset, filed from 1996-07-01 to 2025-02-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.9 million USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 18700000 USD Source
Revenue: 14800000 USD Source

Operating margin

-22.62%

2023 Q4 · %

Exact inputs and evidence

Operating Income: 1365738 USD Source
Operating Income: 2248069 USD Source
Revenue: 18700000 USD Source
Revenue: 14800000 USD Source

Operating cash flow

285 thousand USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 3387863 USD Source
Operating Cash Flow: 3102439 USD Source

Cash and cash equivalents: 49 thousand USD 2023-12-31 Source
Exact value

49015 USD
Long-term debt including current maturities: 11.4 million USD 2023-12-31 Source
Exact value

11416998 USD
Shares outstanding: 40.6 billion shares 2023-12-31 Source
Exact value

40600000000 shares

Reported share-count change

39.52% · 11.5 billion shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

29100000000 shares · 2022-12-31· Source
40600000000 shares · 2023-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-02-14.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2023-12-31
Operating income: 10 of 11 periods available· newest 2023-12-31
Net income: 10 of 11 periods available· newest 2023-12-31
Operating cash flow: 10 of 11 periods available· newest 2023-12-31
Capital expenditure: 8 of 11 periods available· newest 2022-12-31
Total assets: 9 of 11 periods available· newest 2023-12-31
Total liabilities: 9 of 11 periods available· newest 2023-12-31
Current assets: 9 of 11 periods available· newest 2023-12-31
Current liabilities: 9 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 9 of 11 periods available· newest 2023-12-31
Shares outstanding: 9 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+43.8%

Prior period

USD 13 million

2022-01-01 – 2022-12-31
Current period

USD 18.7 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

18700000 − 13000000 = 5700000 USD

13000000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
18700000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CollabRx, Inc. · 2023-12-31 CollabRx, Inc. (edgar:931059) Year-over-year change in Revenue: 5700000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 18700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1283449 Filing: 000149315225006522 Input fundies:Revenue: 13000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1283750 Filing: 000149315225006522
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.4 million

Prior period

−USD 3.3 million

2022-01-01 – 2022-12-31
Current period

−USD 7.7 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-7700000 − -3300000 = -4400000 USD

-3300000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-7700000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CollabRx, Inc. · 2023-12-31 CollabRx, Inc. (edgar:931059) Year-over-year change in Net income: -4400000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1250923 Filing: 000149315225006522 Input fundies:NetIncome: -3300000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1251244 Filing: 000149315225006522
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.61 million

Prior period

−USD 218,348

2022-01-01 – 2022-12-31
Current period

USD 3.39 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

3387863 − -218348 = 3606211 USD

-218348 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
3387863 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CollabRx, Inc. · 2023-12-31 CollabRx, Inc. (edgar:931059) Year-over-year change in Operating cash flow: 3606211 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 3387863 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1178560 Filing: 000149315225006522 Input fundies:OperatingCashFlow: -218348 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1179275 Filing: 000149315225006522
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 18.7 million 100% of revenue
Operating costs Derived USD 17.33 million 93% of revenue
Operating income USD 1.37 million 7.3% of revenue
Tax, interest and other Derived USD 9.07 million 48% of revenue
Net income −USD 7.7 million −41% of revenue

Cash

Operating cash flow USD 3.39 million 18% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 22%73%
2015 Operating loss: operating costs were 347% of revenue.
2017 Operating loss: operating costs were 621% of revenue.
2018 Operating loss: operating costs were 191% of revenue.
2019 Operating loss: operating costs were 198% of revenue.
2020 Operating loss: operating costs were 339% of revenue.
2021 Operating loss: operating costs were 491% of revenue.
2022 Operating loss: operating costs were 111% of revenue.
2023 Net loss: net income was −41% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	57927820	42272826 Derived	15654994	12844962 Derived	2810032	5210163 Derived	Source 2014-01-01 – 2014-12-31: 57927820 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 15654994 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 2810032 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 7701730 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 2491567 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	18393038	63858012 Derived	-45464974	-7875280 Derived	-37589694	-13018164 Derived	Source 2015-01-01 – 2015-12-31: 18393038 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -45464974 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -37589694 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -12561861 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 456303 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	3088216	19164323 Derived	-16076107	39121835 Derived	-55197942	-19135549 Derived	Source 2017-01-01 – 2017-12-31: 3088216 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -16076107 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -55197942 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -17713547 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1422002 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	14548690	27773310 Derived	-13224620	797735 Derived	-14022355	-7891836 Derived	Source 2018-01-01 – 2018-12-31: 14548690 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -13224620 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -14022355 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7678731 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 213105 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	16003443	31702853 Derived	-15699410	32334411 Derived	-48033821	-13529172 Derived	Source 2019-01-01 – 2019-12-31: 16003443 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -15699410 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -48033821 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -13529045 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 127 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	7200000	24395298 Derived	-17195298	1144476 Derived	-18339774	-17299266 Derived	Source 2020-01-01 – 2020-12-31: 7200000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -17195298 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -18339774 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -16928376 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 370890 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	3200000	15720524 Derived	-12520524	-18125681 Derived	5605157	Unavailable	Source 2021-01-01 – 2021-12-31: 3200000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -12520524 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 5605157 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -8900000 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	13000000	14418525 Derived	-1418525	1881475 Derived	-3300000	-253578 Derived	Source 2022-01-01 – 2022-12-31: 13000000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -1418525 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -3300000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -218348 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 35230 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	18700000	17334262 Derived	1365738	9065738 Derived	-7700000	Unavailable	Source 2023-01-01 – 2023-12-31: 18700000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 1365738 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -7700000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 3387863 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 18.7M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	57927820	Revenue: 57927820 Open source
20152015-12-31	Revenue	18393038	Revenue: 18393038 Open source
20172017-12-31	Revenue	3088216	Revenue: 3088216 Open source
20182018-12-31	Revenue	14548690	Revenue: 14548690 Open source
20192019-12-31	Revenue	16003443	Revenue: 16003443 Open source
20202020-12-31	Revenue	7200000	Revenue: 7200000 Open source
20212021-12-31	Revenue	3200000	Revenue: 3200000 Open source
20222022-12-31	Revenue	13000000	Revenue: 13000000 Open source
20232023-12-31	Revenue	18700000	Revenue: 18700000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

43.8% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 57927820 Open source
20152015-12-31	Year over year	-68.2%	Revenue: 18393038 Open source Revenue: 57927820 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 3088216 Open source
20182018-12-31	Year over year	371.1%	Revenue: 14548690 Open source Revenue: 3088216 Open source
20192019-12-31	Year over year	10%	Revenue: 16003443 Open source Revenue: 14548690 Open source
20202020-12-31	Year over year	-55%	Revenue: 7200000 Open source Revenue: 16003443 Open source
20212021-12-31	Year over year	-55.6%	Revenue: 3200000 Open source Revenue: 7200000 Open source
20222022-12-31	Year over year	306.3%	Revenue: 13000000 Open source Revenue: 3200000 Open source
20232023-12-31	Year over year	43.8%	Revenue: 18700000 Open source Revenue: 13000000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 7.3% 2023

Net margin -41.2% 2023

Free cash flow margin -2% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	27%	Operating Income: 15654994 Open source Revenue: 57927820 Open source
20152015-12-31	Operating margin	-247.2%	Operating Income: -45464974 Open source Revenue: 18393038 Open source
20172017-12-31	Operating margin	-520.6%	Operating Income: -16076107 Open source Revenue: 3088216 Open source
20182018-12-31	Operating margin	-90.9%	Operating Income: -13224620 Open source Revenue: 14548690 Open source
20192019-12-31	Operating margin	-98.1%	Operating Income: -15699410 Open source Revenue: 16003443 Open source
20202020-12-31	Operating margin	-238.8%	Operating Income: -17195298 Open source Revenue: 7200000 Open source
20212021-12-31	Operating margin	-391.3%	Operating Income: -12520524 Open source Revenue: 3200000 Open source
20222022-12-31	Operating margin	-10.9%	Operating Income: -1418525 Open source Revenue: 13000000 Open source
20232023-12-31	Operating margin	7.3%	Operating Income: 1365738 Open source Revenue: 18700000 Open source
20142014-12-31	Net margin	4.9%	Net Income: 2810032 Open source Revenue: 57927820 Open source
20152015-12-31	Net margin	-204.4%	Net Income: -37589694 Open source Revenue: 18393038 Open source
20172017-12-31	Net margin	-1,787.4%	Net Income: -55197942 Open source Revenue: 3088216 Open source
20182018-12-31	Net margin	-96.4%	Net Income: -14022355 Open source Revenue: 14548690 Open source
20192019-12-31	Net margin	-300.1%	Net Income: -48033821 Open source Revenue: 16003443 Open source
20202020-12-31	Net margin	-254.7%	Net Income: -18339774 Open source Revenue: 7200000 Open source
20212021-12-31	Net margin	175.2%	Net Income: 5605157 Open source Revenue: 3200000 Open source
20222022-12-31	Net margin	-25.4%	Net Income: -3300000 Open source Revenue: 13000000 Open source
20232023-12-31	Net margin	-41.2%	Net Income: -7700000 Open source Revenue: 18700000 Open source
20142014-12-31	Free cash flow margin	9%	Revenue: 57927820 Open source Operating Cash Flow: 7701730 Open source Capital Expenditure: 2491567 Open source
20152015-12-31	Free cash flow margin	-70.8%	Revenue: 18393038 Open source Operating Cash Flow: -12561861 Open source Capital Expenditure: 456303 Open source
20172017-12-31	Free cash flow margin	-619.6%	Revenue: 3088216 Open source Operating Cash Flow: -17713547 Open source Capital Expenditure: 1422002 Open source
20182018-12-31	Free cash flow margin	-54.2%	Revenue: 14548690 Open source Operating Cash Flow: -7678731 Open source Capital Expenditure: 213105 Open source
20192019-12-31	Free cash flow margin	-84.5%	Revenue: 16003443 Open source Operating Cash Flow: -13529045 Open source Capital Expenditure: 127 Open source
20202020-12-31	Free cash flow margin	-240.3%	Revenue: 7200000 Open source Operating Cash Flow: -16928376 Open source Capital Expenditure: 370890 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 3200000 Open source Operating Cash Flow: -8900000 Open source
20222022-12-31	Free cash flow margin	-2%	Revenue: 13000000 Open source Operating Cash Flow: -218348 Open source Capital Expenditure: 35230 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 18700000 Open source Operating Cash Flow: 3387863 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 3.4M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	7701730	Operating Cash Flow: 7701730 Open source
20152015-12-31	Operating cash flow	-12561861	Operating Cash Flow: -12561861 Open source
20172017-12-31	Operating cash flow	-17713547	Operating Cash Flow: -17713547 Open source
20182018-12-31	Operating cash flow	-7678731	Operating Cash Flow: -7678731 Open source
20192019-12-31	Operating cash flow	-13529045	Operating Cash Flow: -13529045 Open source
20202020-12-31	Operating cash flow	-16928376	Operating Cash Flow: -16928376 Open source
20212021-12-31	Operating cash flow	-8900000	Operating Cash Flow: -8900000 Open source
20222022-12-31	Operating cash flow	-218348	Operating Cash Flow: -218348 Open source
20232023-12-31	Operating cash flow	3387863	Operating Cash Flow: 3387863 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -253.6K 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	5210163	Operating Cash Flow: 7701730 Open source Capital Expenditure: 2491567 Open source
20152015-12-31	Free cash flow	-13018164	Operating Cash Flow: -12561861 Open source Capital Expenditure: 456303 Open source
20172017-12-31	Free cash flow	-19135549	Operating Cash Flow: -17713547 Open source Capital Expenditure: 1422002 Open source
20182018-12-31	Free cash flow	-7891836	Operating Cash Flow: -7678731 Open source Capital Expenditure: 213105 Open source
20192019-12-31	Free cash flow	-13529172	Operating Cash Flow: -13529045 Open source Capital Expenditure: 127 Open source
20202020-12-31	Free cash flow	-17299266	Operating Cash Flow: -16928376 Open source Capital Expenditure: 370890 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -8900000 Open source
20222022-12-31	Free cash flow	-253578	Operating Cash Flow: -218348 Open source Capital Expenditure: 35230 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: 3387863 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

281.9% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	57.9%	Total Liabilities: 20716930 Open source Total Assets: 35760754 Open source
20152015-12-31	Liabilities / assets	104.1%	Total Liabilities: 30563725 Open source Total Assets: 29369926 Open source
20172017-12-31	Liabilities / assets	652.8%	Total Liabilities: 41068961 Open source Total Assets: 6290794 Open source
20182018-12-31	Liabilities / assets	313%	Total Liabilities: 44447717 Open source Total Assets: 14199300 Open source
20192019-12-31	Liabilities / assets	568.3%	Total Liabilities: 83576905 Open source Total Assets: 14707659 Open source
20202020-12-31	Liabilities / assets	499.8%	Total Liabilities: 61279843 Open source Total Assets: 12262091 Open source
20212021-12-31	Liabilities / assets	239%	Total Liabilities: 46936120 Open source Total Assets: 19634596 Open source
20222022-12-31	Liabilities / assets	241.4%	Total Liabilities: 49667350 Open source Total Assets: 20572762 Open source
20232023-12-31	Liabilities / assets	281.9%	Total Liabilities: 57096480 Open source Total Assets: 20252940 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.16× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	1.12×	Current Assets: 20328721 Open source Current Liabilities: 18148013 Open source
20152015-12-31	Current assets / current liabilities	1.24×	Current Assets: 21988857 Open source Current Liabilities: 17770170 Open source
20172017-12-31	Current assets / current liabilities	0.09×	Current Assets: 3385645 Open source Current Liabilities: 37316939 Open source
20182018-12-31	Current assets / current liabilities	0.12×	Current Assets: 5122270 Open source Current Liabilities: 44416174 Open source
20192019-12-31	Current assets / current liabilities	0.06×	Current Assets: 5345103 Open source Current Liabilities: 83418195 Open source
20202020-12-31	Current assets / current liabilities	0.05×	Current Assets: 2723505 Open source Current Liabilities: 59178050 Open source
20212021-12-31	Current assets / current liabilities	0.1×	Current Assets: 4719903 Open source Current Liabilities: 46361863 Open source
20222022-12-31	Current assets / current liabilities	0.13×	Current Assets: 6363162 Open source Current Liabilities: 49308157 Open source
20232023-12-31	Current assets / current liabilities	0.16×	Current Assets: 6944959 Open source Current Liabilities: 42505691 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	USD 2.81 million Exact value Exact value: 2810032 USD 2014-01-01 – 2014-12-31: 2810032 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2014-12-31 CollabRx, Inc. (edgar:931059) Net Income: 2810032 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2810032 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000101968716006367/rnva-20151231.xml#209978 Filing: 000101968716006367 The citation records this snapshot. The page link may show a newer release later.	USD 7.7 million Exact value Exact value: 7701730 USD 2014-01-01 – 2014-12-31: 7701730 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2014-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: 7701730 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7701730 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000101968716006367/rnva-20151231.xml#217301 Filing: 000101968716006367 The citation records this snapshot. The page link may show a newer release later.	USD 2.49 million Exact value Exact value: 2491567 USD 2014-01-01 – 2014-12-31: 2491567 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2014-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 2491567 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2491567 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000101968716006367/rnva-20151231.xml#217708 Filing: 000101968716006367 The citation records this snapshot. The page link may show a newer release later.	USD 5.21 million Calculation and evidence 7701730 − 2491567 USD Exact free cash flow: 5210163 USD 2014-01-01 – 2014-12-31: 7701730 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 2491567 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2014-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: 5210163 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7701730 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000101968716006367/rnva-20151231.xml#217301 Filing: 000101968716006367 Input fundies:CapitalExpenditure: 2491567 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000101968716006367/rnva-20151231.xml#217708 Filing: 000101968716006367 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 37.59 million Exact value Exact value: -37589694 USD 2015-01-01 – 2015-12-31: -37589694 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2015-12-31 CollabRx, Inc. (edgar:931059) Net Income: -37589694 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -37589694 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000168316817000881/rnva-20161231.xml#227029 Filing: 000168316817000881 The citation records this snapshot. The page link may show a newer release later.	−USD 12.56 million Exact value Exact value: -12561861 USD 2015-01-01 – 2015-12-31: -12561861 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2015-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -12561861 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12561861 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000168316817000881/rnva-20161231.xml#231072 Filing: 000168316817000881 The citation records this snapshot. The page link may show a newer release later.	USD 456,303 Exact value Exact value: 456303 USD 2015-01-01 – 2015-12-31: 456303 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2015-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 456303 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 456303 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000168316817000881/rnva-20161231.xml#231480 Filing: 000168316817000881 The citation records this snapshot. The page link may show a newer release later.	−USD 13.02 million Calculation and evidence -12561861 − 456303 USD Exact free cash flow: -13018164 USD 2015-01-01 – 2015-12-31: -12561861 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 456303 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2015-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -13018164 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12561861 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000168316817000881/rnva-20161231.xml#231072 Filing: 000168316817000881 Input fundies:CapitalExpenditure: 456303 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000168316817000881/rnva-20161231.xml#231480 Filing: 000168316817000881 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 32.61 million Exact value Exact value: -32613687 USD 2016-01-01 – 2016-12-31: -32613687 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2016-12-31 CollabRx, Inc. (edgar:931059) Net Income: -32613687 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32613687 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315218005716/rnva-20171231.xml#235717 Filing: 000149315218005716 The citation records this snapshot. The page link may show a newer release later.	−USD 19.86 million Exact value Exact value: -19863680 USD 2016-01-01 – 2016-12-31: -19863680 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2016-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -19863680 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19863680 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315218005716/rnva-20171231.xml#976845 Filing: 000149315218005716 The citation records this snapshot. The page link may show a newer release later.	USD 14,123 Exact value Exact value: 14123 USD 2016-01-01 – 2016-12-31: 14123 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2016-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 14123 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14123 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315218005716/rnva-20171231.xml#269224 Filing: 000149315218005716 The citation records this snapshot. The page link may show a newer release later.	−USD 19.88 million Calculation and evidence -19863680 − 14123 USD Exact free cash flow: -19877803 USD 2016-01-01 – 2016-12-31: -19863680 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 14123 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2016-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -19877803 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19863680 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315218005716/rnva-20171231.xml#976845 Filing: 000149315218005716 Input fundies:CapitalExpenditure: 14123 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315218005716/rnva-20171231.xml#269224 Filing: 000149315218005716 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 55.2 million Exact value Exact value: -55197942 USD 2017-01-01 – 2017-12-31: -55197942 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2017-12-31 CollabRx, Inc. (edgar:931059) Net Income: -55197942 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55197942 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315219015714/rnva-20181231.xml#286678 Filing: 000149315219015714 The citation records this snapshot. The page link may show a newer release later.	−USD 17.71 million Exact value Exact value: -17713547 USD 2017-01-01 – 2017-12-31: -17713547 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2017-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -17713547 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17713547 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315219015714/rnva-20181231.xml#1841422 Filing: 000149315219015714 The citation records this snapshot. The page link may show a newer release later.	USD 1.42 million Exact value Exact value: 1422002 USD 2017-01-01 – 2017-12-31: 1422002 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2017-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 1422002 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1422002 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315219015714/rnva-20181231.xml#327510 Filing: 000149315219015714 The citation records this snapshot. The page link may show a newer release later.	−USD 19.14 million Calculation and evidence -17713547 − 1422002 USD Exact free cash flow: -19135549 USD 2017-01-01 – 2017-12-31: -17713547 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1422002 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2017-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -19135549 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17713547 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315219015714/rnva-20181231.xml#1841422 Filing: 000149315219015714 Input fundies:CapitalExpenditure: 1422002 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315219015714/rnva-20181231.xml#327510 Filing: 000149315219015714 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 14.02 million Exact value Exact value: -14022355 USD 2018-01-01 – 2018-12-31: -14022355 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2018-12-31 CollabRx, Inc. (edgar:931059) Net Income: -14022355 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14022355 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315220011988/rnva-20191231.xml#280260 Filing: 000149315220011988 The citation records this snapshot. The page link may show a newer release later.	−USD 7.68 million Exact value Exact value: -7678731 USD 2018-01-01 – 2018-12-31: -7678731 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2018-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -7678731 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7678731 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315220011988/rnva-20191231.xml#337408 Filing: 000149315220011988 The citation records this snapshot. The page link may show a newer release later.	USD 213,105 Exact value Exact value: 213105 USD 2018-01-01 – 2018-12-31: 213105 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2018-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 213105 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 213105 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315220011988/rnva-20191231.xml#281333 Filing: 000149315220011988 The citation records this snapshot. The page link may show a newer release later.	−USD 7.89 million Calculation and evidence -7678731 − 213105 USD Exact free cash flow: -7891836 USD 2018-01-01 – 2018-12-31: -7678731 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 213105 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2018-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -7891836 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7678731 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315220011988/rnva-20191231.xml#337408 Filing: 000149315220011988 Input fundies:CapitalExpenditure: 213105 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315220011988/rnva-20191231.xml#281333 Filing: 000149315220011988 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 48.03 million Exact value Exact value: -48033821 USD 2019-01-01 – 2019-12-31: -48033821 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2019-12-31 CollabRx, Inc. (edgar:931059) Net Income: -48033821 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48033821 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315221008884/rnva-20201231.xml#261069 Filing: 000149315221008884 The citation records this snapshot. The page link may show a newer release later.	−USD 13.53 million Exact value Exact value: -13529045 USD 2019-01-01 – 2019-12-31: -13529045 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2019-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -13529045 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13529045 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315221008884/rnva-20201231.xml#377765 Filing: 000149315221008884 The citation records this snapshot. The page link may show a newer release later.	USD 127 Exact value Exact value: 127 USD 2019-01-01 – 2019-12-31: 127 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2019-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 127 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 127 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315221008884/rnva-20201231.xml#261929 Filing: 000149315221008884 The citation records this snapshot. The page link may show a newer release later.	−USD 13.53 million Calculation and evidence -13529045 − 127 USD Exact free cash flow: -13529172 USD 2019-01-01 – 2019-12-31: -13529045 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 127 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2019-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -13529172 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13529045 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315221008884/rnva-20201231.xml#377765 Filing: 000149315221008884 Input fundies:CapitalExpenditure: 127 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315221008884/rnva-20201231.xml#261929 Filing: 000149315221008884 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 18.34 million Exact value Exact value: -18339774 USD 2020-01-01 – 2020-12-31: -18339774 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2020-12-31 CollabRx, Inc. (edgar:931059) Net Income: -18339774 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18339774 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315222010066/form10-k.htm#1055957 Filing: 000149315222010066 The citation records this snapshot. The page link may show a newer release later.	−USD 16.93 million Exact value Exact value: -16928376 USD 2020-01-01 – 2020-12-31: -16928376 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2020-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -16928376 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16928376 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315222010066/form10-k.htm#1089231 Filing: 000149315222010066 The citation records this snapshot. The page link may show a newer release later.	USD 370,890 Exact value Exact value: 370890 USD 2020-01-01 – 2020-12-31: 370890 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2020-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 370890 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 370890 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315222010066/form10-k.htm#1090957 Filing: 000149315222010066 The citation records this snapshot. The page link may show a newer release later.	−USD 17.3 million Calculation and evidence -16928376 − 370890 USD Exact free cash flow: -17299266 USD 2020-01-01 – 2020-12-31: -16928376 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 370890 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2020-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -17299266 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16928376 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315222010066/form10-k.htm#1089231 Filing: 000149315222010066 Input fundies:CapitalExpenditure: 370890 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315222010066/form10-k.htm#1090957 Filing: 000149315222010066 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 5.61 million Exact value Exact value: 5605157 USD 2021-01-01 – 2021-12-31: 5605157 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2021-12-31 CollabRx, Inc. (edgar:931059) Net Income: 5605157 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5605157 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315223012549/form10-k.htm#1084606 Filing: 000149315223012549 The citation records this snapshot. The page link may show a newer release later.	−USD 8.9 million Exact value Exact value: -8900000 USD 2021-01-01 – 2021-12-31: -8900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2021-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -8900000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8900000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315223012549/form10-k.htm#1204797 Filing: 000149315223012549 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 3.3 million Exact value Exact value: -3300000 USD 2022-01-01 – 2022-12-31: -3300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2022-12-31 CollabRx, Inc. (edgar:931059) Net Income: -3300000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3300000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1251244 Filing: 000149315225006522 The citation records this snapshot. The page link may show a newer release later.	−USD 218,348 Exact value Exact value: -218348 USD 2022-01-01 – 2022-12-31: -218348 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2022-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: -218348 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -218348 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1179275 Filing: 000149315225006522 The citation records this snapshot. The page link may show a newer release later.	USD 35,230 Exact value Exact value: 35230 USD 2022-01-01 – 2022-12-31: 35230 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CollabRx, Inc. · 2022-12-31 CollabRx, Inc. (edgar:931059) Capital Expenditure: 35230 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35230 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315223012549/form10-k.htm#1136555 Filing: 000149315223012549 The citation records this snapshot. The page link may show a newer release later.	−USD 253,578 Calculation and evidence -218348 − 35230 USD Exact free cash flow: -253578 USD 2022-01-01 – 2022-12-31: -218348 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 35230 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CollabRx, Inc. · 2022-12-31 CollabRx, Inc. (edgar:931059) Free cash flow: -253578 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -218348 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1179275 Filing: 000149315225006522 Input fundies:CapitalExpenditure: 35230 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315223012549/form10-k.htm#1136555 Filing: 000149315223012549 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 7.7 million Exact value Exact value: -7700000 USD 2023-01-01 – 2023-12-31: -7700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CollabRx, Inc. · 2023-12-31 CollabRx, Inc. (edgar:931059) Net Income: -7700000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1250923 Filing: 000149315225006522 The citation records this snapshot. The page link may show a newer release later.	USD 3.39 million Exact value Exact value: 3387863 USD 2023-01-01 – 2023-12-31: 3387863 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CollabRx, Inc. · 2023-12-31 CollabRx, Inc. (edgar:931059) Operating Cash Flow: 3387863 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:50:17Z Snapshot: 5083447bd27c085838821994997891c561f2b09105583b68d5909bc2ca6a1c59 Dimensions: Consolidated View: https://fundies.io/companies/edgar/931059/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3387863 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/931059/000149315225006522/form10-k.htm#1178560 Filing: 000149315225006522 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

191 filings · 4,138 latest values · 4,155 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000931059, 931059, RNVA, edgar:931059

Also known as CollabRx, Inc., CollabRx, Inc. , RENNOVA HEALTH, INC., RENNOVA HEALTH, INC., Rennova Health, Inc., TEGAL CORP /DE/

CollabRx, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation